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Background Myocardial infarction is most commonly caused by thrombosis occurring on a background of coronary atheroscler-
osis, resulting in reduced coronary flow. Less often, myocardial infarction can occur in the absence of coronary
disease. The pathomechanism of myocardial infarction in such patients is heterogeneous and more challenging to
diagnose and treat. European Society of Cardiology published a position paper on myocardial infarction in patients
with non-obstructive coronary disease, with definitions and recommendations for investigations, in what has hither-
to been an under-recognized and under-investigated Cinderella-like condition. However, the importance of obtain-
ing a diagnosis is all the more important, since one treatment approach with revascularization and antithrombotic
treatment does not ‘fit all’.
...................................................................................................................................................................................................
Case summary A 70-year-old male patient presented with chest pain at rest, associated with rise in troponin and without ECG
changes. A diagnosis of non-ST elevation myocardial infarction was made. Coronary angiography showed a smooth
stenosis which resolved with administration of intracoronary nitrate. A diagnosis of coronary artery spasm was
made, and treatment initiated. After 18 months, the patient had recurrent chest pains at rest, unresponsive to gly-
ceryl trinitrate (GTN). Cardiac magnetic resonance revealed extension of subendocardial infarction, without indu-
cible ischaemia. CT coronary angiogram (CTCA) showed non-obstructive coronaries. Blood tests showed signifi-
cant eosinophilia, raised troponin, and C-reactive protein (CRP) that fluctuated without correlation with symptoms
or any ECG changes. A diagnosis of Churg–Strauss syndrome was made, and immunosuppression commenced.
...................................................................................................................................................................................................
Discussion Churg–Strauss syndrome is an autoimmune vasculitis in patients with history of atopy or late-onset
asthma which when involving coronary arteries can lead to myocardial injury mimicking acute coronary syn-
drome (ACS). Identification is important to allow initiation of immunosuppression which can prevent devel-
opment or progression.
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Myocardial infarction is most commonly caused by thrombus forma-
tion superimposed on coronary artery narrowing resulting from ath-
erosclerosis. Recently, a new term of interest has been coined by
researchers to describe a different group of patients who has myo-
cardial infarction that are not associated with significant coronary ar-
tery disease—myocardial infarction with non-obstructive coronary
arteries (MINOCA). A recent European Society of Cardiology (ESC)
working group position paper1 has provided clinicians with good
guidance on how to further investigate so as to appropriately manage
this group of patients.
Timeline
Case presentation
A 70-year-old male patient with a previous history of multiple scler-
osis, previously successfully resected colon cancer 10 years earlier
and late-onset asthma (age of 62 years) presented with retrosternal
chest pain, small troponin rise, and without ECG changes. Physical
examination revealed no abnormalities of the cardiovascular and re-
spiratory system. Echocardiography showed normal left ventricular
function with no regional wall motion abnormality and no valvular
disease. A diagnosis of non-ST elevation myocardial infarction was
made, and diagnostic coronary angiography showed a smooth sten-
osis in the right coronary artery (RCA) and unobstructed left coron-
ary artery (Supplementary material online, Videos S1 and S2). He was
listed for angioplasty to the RCA but upon reimaging, the RCA
looked smooth and unobstructed. However, the mid-circumflex ar-
tery now had a smooth stenosis which resolved with administration
of intracoronary isosorbide dinitrate (Supplementary material online,
Videos S3 and S4). A diagnosis of coronary artery spasm was made,
and the patient was treated with aspirin and he was started on oral
isosorbide mononitrate. A month later he was admitted with anterior
ST-segment elevation which completely resolved with administration
of sublingual glyceryl trinitrate in the emergency room. The chest
pains continued intermittently at rest and diltiazem and nicorandil
were added in stepwise fashion to try and settle ongoing symptoms.
Cardiac magnetic resonance (CMR) imaging revealed small areas of
myocardial infarction in both the RCA and the LAD territories. Due
to concern over possible ongoing infarction due to spasm, clopidog-
rel 75 mg o.d. was added and continued long-term. Over the next
18 months, the patient remained stable, with minimal symptoms and
no changes on serial CMR scans at 6 monthly intervals. He was con-
tinued on maximal antianginal therapy, dual antiplatelet therapy, and
advised to avoid beta-blockers and phosphodiesterase 5 inhibitors.
He subsequently represented with further episodes of atypical
chest pain at rest, unresponsive to glyceryl trinitrate (GTN) and
First presentation • Admission with chest pain, normal ECG with troponin rise treated as non-ST-segment elevation myocardial infarction
• Coronary angiogram showing no obstructive lesion but tendency to severe coronary spasm
• Outpatient cardiac magnetic resonance (CMR) showed subendocardial infarction in inferoseptal and anteroseptal areas
• Treated as coronary artery vasospasm
December 2013
2 years later • Further episodes of chest pain and raised troponin
• Repeat CMR (prior to clinic) showed extension of subendocardial infarction
• CT coronary angiogram (CTCA) showed no obstructive coronary disease
• Significant eosinophilia noted with raised C-reactive protein (CRP)
• Referral to rheumatology
November 2015–
November 2017
2 months later • Churg–Strauss syndrome diagnosed clinically
• Started on immunosuppression with steroidsJanuary 2018
9 months later • Reduced requirement for glyceryl trinitrate (GTN) spray
• Troponin and eosinophil levels returned to normal
• Symptom free since start of treatment
October 2018
Learning points
• Myocardial infarction with non-obstructive coronary arteries is
a working diagnosis—further investigations should be per-
formed to determine the underlying cause so appropriate
treatment can be initiated.
• The lack of correlation between the extent of epicardial cor-
onary disease and cardiac magnetic resonance findings should
point to systemic causes.
• The history of myocardial infarction, late-onset asthma com-
bined with eosinophilia is highly suggestive of Churg–Strauss
syndrome (eosinophilic granulomatosis with polyangiitis) with
cardiac involvement.
• This is an important diagnosis to make, as without immuno-
suppression, ongoing myocardial infarction and loss of myocar-
dium may ensue, which can be halted by immunosuppression.





























associated marked troponin rise (troponin I > 400 ng/L [normal range
<16 ng/L]), that fluctuated over a couple of months with no correl-
ation with symptoms or any ECG changes. Full blood count was nor-
mal apart from raised eosinophils (4.3 109/L [normal range 0.02–
0.5 109/L]) with normal renal and liver function tests. Erythrocyte
sedimentation rate (ESR) was normal (<5 mm/h) and C-reactive pro-
tein (CRP) 5.7 mg/L. Over the next few weeks, CRP rose to 28 and
troponin fluctuated, albeit markedly elevated, with no correlation
with symptoms. Coronary anatomy was revisited with a CT coronary
angiography which showed a calcium score of 202 with no obstruct-
ive lesions.
Repeat CMR (Figure 1) revealed normal right and left ventricular
volumes and function. In the late gadolinium phase, there were two
separate regions of infarction. There was infarction in the inferior/
inferoseptal wall from the basal to apical level. This was predominant-
ly transmural (>50%) in the inferior and inferoseptal wall at the basal
to mid-level. There was some new extension into the basal inferolat-
eral wall not seen on the previous scan that was also transmural.
Separately, there was localized infarction (>50% transmurality) in the
basal anterior wall.
Given the presence of eosinophilia, recurrent episodic myocardial
infarction and the lack of correlation between the extent of epicardial
coronary disease and CMR findings, combined with the suspicious
history of late-onset asthma, a diagnosis of Churg–Strauss syndrome
was postulated. The patient was treated with prednisolone 30 mg
o.d. and azathioprine 50 mg t.d.s. Following immunosuppressive
Figure 1 Cardiac magnetic resonance imaging showing late gadolinium enhancement in basal to apical inferior/inferoseptal wall (red arrow) and
basal anterior wall (green arrow).













































.therapy, the chest pains resolved with corresponding normalization
of eosinophil and troponin levels. antineutrophil cytoplasmic anti-
body (ANCA) levels checked in the non-acute phase was normal
with myeloperoxidase (MPO) <0.3 (normal range < 3.5 IU/mL) and
PR3 < 0.7 (normal range < 2.0 IU/mL). Nine months after treatment
began, his medication has been gradually weaned to prednisolone
5 mg o.d. and azathioprine 50 mg o.d. with a plan for slow ongoing
tapering of both.
Discussion
The vast majority of patients presenting with myocardial infarction
have underlying coronary artery disease. Myocardial infarction with
non-obstructive coronary arteries is a new nomenclature devised for
an often-overlooked group of patients, namely those with myocardial
infarction despite the absence of significant obstructive coronary dis-
ease. The European Society of Cardiology Working Group Position
Paper on Myocardial Infarction with Non-obstructive Coronary
Arteries1 has highlighted that this is a very heterogeneous group of
patients with varied pathomechanism of myocardial infarction, although
some 33% are reportedly attributed to myocarditis.2 Some 25% of
patients with MINOCA continue to experience angina 12 months after
the index infarction3 presumably at least in part because of challenges
identifying the underlying cause. Making the correct diagnosis is essen-
tial, in order to successfully treat the under underlying condition and
prevent recurrent infarction and loss of myocardium.
In this case, the presence of a constellation of late-onset asthma,
eosinophilia, rise in troponin, and inflammatory markers unrelated to
symptoms, with recurrent symptoms at rest despite maximal antian-
ginal and dual antiplatelet therapy pointed towards a systemic cause
which ultimately led to a diagnosis of Churg–Strauss syndrome with
cardiac involvement.
Churg–Strauss syndrome, recently renamed eosinophilic granulo-
matosis with polyangiitis (EGPA) is an autoimmune vasculitis affecting
medium to small vessel and should be suspected in patients with a
history of atopy or late-onset asthma. Two of the most commonly
used classifications include the American College of Rheumatology
(ACR)4 which has developed six diagnostic criteria for Churg–
Strauss syndrome which includes asthma, eosinophilia greater than
10% on differential white blood cell (WBC) count, mononeuropathy
(including multiplex) or polyneuropathy, non-fixed pulmonary infil-
trates on roentgenography, paranasal sinus abnormality, and biopsy
containing a blood vessel with extravascular eosinophils and the
Lanham criteria5 which includes asthma, eosinophils > 1500 cells/mL,
and systemic vasculitis involving two or more extra-pulmonary
organs. In our case, the patient fits two out of the six ACR diagnostic
criteria and two out of three of the Lanham criteria. Although neur-
opathy, pulmonary infiltrates and positive biopsy were not available,
these are not strictly required for the diagnosis. The ACR definition
paper states that the combination of only two criteria, namely a his-
tory of asthma together with eosinophilia >10% on a WBC differen-
tial correctly classified 90% of Churg–Strauss syndrome cases and has
a sensitivity of 90% and a specificity of 99.7%.4
Approximately 60% of patients with Churg–Strauss have cardiac
involvement which includes vasculitic lesions in myocardium and cor-
onary vessels.6 It can result in myocardial infarction, heart failure,
pericarditis, and myocarditis. Presence of cardiac involvement is asso-
ciated with an increased risk of mortality.7 There have been a few
cases describing coronary vasospasm in the context of Churg–
Strauss,8–10 but its pathophysiology remains unclear. There are prob-
able links between allergic diseases and coronary vasospasm—local
inflammatory response inducing arterial wall hyper-reactivity.11 In
our case, given that the absence of correlation between the infarcted
areas and coronary anatomy, the cause of his presentation might be
due to multiple factors i.e. coronary vasospasm, vasculitis, and even
myocarditis.
The mainstay of treatment is immunosuppression with corticoste-
roids.12 The use of additional cytotoxic drugs like cyclophosphamide is
normally reserved for patients with life or organ threatening disease
manifestations which can be used to induce remission with azathio-
prine or methotrexate being recommended as maintenance therapy.12
This case illustrates non-atheromatous cause of myocardial
infarction that is rare and challenging to diagnose. It also emphasizes
the importance of ongoing tests in patients with unexplained chest
pain and troponin rise, to ensure appropriate treatment, to reduce
the risk of recurrent infarction, prevent loss of myocardium, and im-
prove prognosis.
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